Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for fibrosis and related diseases. The company develops integrin-based therapeutics, with product candidates targeting fibrotic conditions. Pliant has pursued orphan drug and Fast Track designations for its pipeline and has engaged in research collaborations and license agreements to advance its drug development programs.
Q2 FY2026 — expected 2026-08-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-11 | 2025-12-31 | 0001746473-26-000037 | EDGAR | 79K words |
| 2025-03-03 | 2024-12-31 | 0001746473-25-000054 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0001746473-24-000043 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001746473-23-000008 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001746473-22-000010 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001564590-21-013589 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001746473-25-000175 | EDGAR | 54K words |
| 2025-08-07 | 2025-06-30 | 0001746473-25-000150 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001746473-25-000099 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001746473-24-000171 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001746473-24-000145 | EDGAR | — |
| 2024-05-06 | 2024-03-31 | 0001746473-24-000076 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001746473-23-000074 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001746473-23-000053 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001746473-23-000031 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001746473-22-000031 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001746473-22-000027 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001746473-22-000021 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001746473-26-000046 | EDGAR | 1K words |
| 2026-03-11 | 0001746473-26-000039 | EDGAR | — |
| 2026-03-03 | 0001746473-26-000024 | EDGAR | — |
| 2025-12-16 | 0001746473-25-000182 | EDGAR | — |
| 2025-12-08 | 0001746473-25-000179 | EDGAR | — |
| 2025-11-06 | 0001746473-25-000173 | EDGAR | — |
| 2025-10-24 | 0001746473-25-000159 | EDGAR | — |
| 2025-10-20 | 0001193125-25-243619 | EDGAR | — |
| 2025-08-07 | 0001746473-25-000149 | EDGAR | — |
| 2025-06-09 | 0001746473-25-000105 | EDGAR | — |
100 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001746473 |
| Ticker | PLRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.pliantrx.com |
| Listed | 2020-06-03 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report